Journal profile · RHEUMATOLOGY
Modern Rheumatology Case Reports
ISSN 2472-5625 · Oxford University Press
Modern Rheumatology Case Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.8 (journal website); hybrid open access; APC about USD 1,071; median 90 days to acceptance (105 articles, last 24 months); 86 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Modern Rheumatology Case Reports is published by Oxford University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Vasculitis and related conditions, Systemic Lupus Erythematosus Research and Inflammatory Myopathies and Dermatomyositis, together about 30.1% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Modern Rheumatology Case Reports is an online-only journal dedicated to publishing original single and series case reports and letters in English on rheumatism, connective tissue diseases, musculoskeletal disorders including osteoporosis, orthopedic/spine surgery, rehabilitation and their associated areas such as pathology, physiology, immunology, microbiology and pharmacology. We encourage case reports worthy of discussion and clinical lessons particularly around aspects of differential diagnosis, decision making, management, treatment approach, uncommon adverse events, clinical guidelines and pathology.
From the journal's Aims & Scope
Research area (LetPub): RHEUMATOLOGY
Editor-in-chief Yoshiya TanakaPublisher website
Editorial board by country: none in mainland China; most named Japan 25, Hong Kong, China 1, Taiwan, China 1, United States 1, United Kingdom 1 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Vasculitis and related conditionsMedicine14.5%
- Systemic Lupus Erythematosus ResearchMedicine8.7%
- Inflammatory Myopathies and DermatomyositisMedicine6.9%
- Eosinophilic Disorders and SyndromesMedicine6.9%
- IgG4-Related and Inflammatory DiseasesMedicine5.8%
- Autoimmune and Inflammatory Disorders ResearchMedicine4.9%
- Sarcoidosis and Beryllium Toxicity ResearchMedicine4.2%
- Systemic Sclerosis and Related DiseasesMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.8Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- CiteScore (publisher) 2025
- 1.8Publisher website ·
- SJR 2026-06
- 0.34LetPub ·
- SNIP 2026-06
- 0.46LetPub ·
- h-index
- 15OpenAlex ·
- i10-index
- 49OpenAlex ·
- 2-year mean citedness
- 0.9OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 15.81%LetPub ·
Volume
- Articles per year
- 78LetPub ·
- Downloads per year (publisher) 2025
- 63,420Publisher website ·
Articles by year OpenAlex count · 746 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 87 | 27 | 19 |
| 2025 | 86 | 19 | 63 |
| 2024 | 88 | 30 | 154 |
| 2023 | 74 | 22 | 246 |
| 2022 | 100 | 17 | 496 |
| 2021 | 86 | 7 | 466 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
90 daysMedian, submission to acceptance · P25–P75 68 days – 120 days
- Acceptance to online
- median 31 days (10 articles)
- Submission to online
- median 102 days
- Sample
- 105 articles with submission and acceptance dates (239 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision 2025
- 22 daysPublisher website ·
- Submission to final decision 2025
- 31 daysPublisher website ·
- Acceptance to publication
- 15 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,071 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- ISSN
- 2472-5625
- Latest issue on the website
- Volume 10, Issue 2 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Modern Rheumatology Case Reports
What CAS zone is Modern Rheumatology Case Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Modern Rheumatology Case Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Modern Rheumatology Case Reports?
The journal's website gives an impact factor of 1.8 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.8, h-index 15.
How long does peer review take at Modern Rheumatology Case Reports?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 68–120 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Modern Rheumatology Case Reports based?
Of the 32 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (25), Hong Kong, China (1) and Taiwan, China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Modern Rheumatology Case Reports?
According to LetPub and DOAJ records, Modern Rheumatology Case Reports is indexed in ESCI and Scopus. The journal's website also lists Web of Science, MEDLINE and PubMed; that list has not been checked against each database.
Is Modern Rheumatology Case Reports open access, and what is the APC?
Modern Rheumatology Case Reports is a hybrid journal. For open-access publication: APC about USD 1,071.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .